You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

palbociclib

Showing 1 - 25 of 156
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Head Neck Cancer Trial in Seoul (Palbociclib, Cetuximab, Fulvestrant)

Not yet recruiting
  • Breast Cancer
  • Head and Neck Cancer
  • Palbociclib
  • +3 more
  • Seoul, Seoul-teukbyeolsi [seoul], Korea, Republic of
    Samsung Medical Center
Jun 28, 2022

Advanced Dedifferentiated Liposarcoma, Locally Advanced Dedifferentiated Liposarcoma, Metastatic Dedifferentiated Liposarcoma

Not yet recruiting
  • Advanced Dedifferentiated Liposarcoma
  • +5 more
  • Palbociclib
  • +5 more
  • (no location specified)
Jan 11, 2023

DCIS Trial in Washington (Palbociclib)

Recruiting
  • DCIS
  • Palbociclib
  • Washington, District of Columbia
    MedStar Georgetown University Hospital
Apr 5, 2022

Advanced Clear Cell Renal Cell Carcinoma Trial in Boston (Axitinib, Palbociclib, Avelumab)

Not yet recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • Boston, Massachusetts
  • +2 more
Jun 27, 2022

Head and Neck Squamous Cell Carcinoma Trial in Saint Louis (drug, radiation, procedure)

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Palbociclib
  • +5 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Feb 25, 2022

Patterns and Clinical Outcomes of Palbociclib Treated Israel

Completed
  • Metastatic Breast Cancer
  • palbociclib
  • Herzliya Pituach, Israel
    Pfizer Pharmaceuticals Israel Ltd.
Jan 20, 2022

COVID-19 Trial in Brandenburg an der Havel (Palbociclib)

Active, not recruiting
  • COVID-19
  • Palbociclib
  • Brandenburg an der Havel, Germany
    Universitätsklinikum Brandenburg an der Havel
May 11, 2022

Renal Cell Carcinoma Trial in Macquarie University, Haifa (Belzutifan, Palbociclib)

Recruiting
  • Renal Cell Carcinoma
  • Macquarie University, New South Wales, Australia
  • +1 more
Aug 15, 2022

Breast Tumor Female Trial in Melbourne (Venetoclax, Palbociclib, Letrozole)

Recruiting
  • Breast Neoplasm Female
  • Melbourne, Victoria, Australia
  • +2 more
Mar 10, 2022

Breast Cancer Stage IV, Unresectable Locally Advanced Invasive Breast Cancer, Metastatic Invasive Breast Cancer Trial in Boston

Completed
Has Results
  • Breast Cancer Stage IV
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jun 27, 2022

Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Therapy Trial in Taipei City, Taipei (Palbociclib, Ribociclib,

Recruiting
  • Breast Cancer
  • +2 more
  • Palbociclib
  • +3 more
  • Taipei City, Taiwan
  • +1 more
Mar 15, 2023

Metastatic Breast Cancer Trial in United States (Palbociclib, Fulvestrant)

Recruiting
  • Metastatic Breast Cancer
  • Washington, District of Columbia
  • +4 more
Jan 10, 2022

Metastatic Breast Cancer Trial in Pittsburgh (Fulvestrant, Tamoxifen, Palbociclib)

Active, not recruiting
  • Metastatic Breast Cancer
  • Pittsburgh, Pennsylvania
    Magee-Womens Hospital UPMC
Jul 22, 2021

Head and Neck Squamous Cell Carcinoma Trial in La Jolla (Avelumab, Palbociclib, Cetuximab)

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • La Jolla, California
    UC San Diego Moores Cancer Center
Feb 16, 2022

Real-World Evidence In Patients Treated With Palbociclib

Recruiting
  • Metastatic Breast Cancer
  • Palbociclib
  • Timisoara, Timiș, Romania
    Asociatia Oncohelp - Centrul de Oncologie Oncohelp
Feb 15, 2022

Advanced Solid Tumor Trial in Houston, San Antonio (MRTX849, Palbociclib)

Recruiting
  • Advanced Solid Tumor
  • Houston, Texas
  • +1 more
Feb 18, 2022

Breast Cancer Trial (Gedatolisib, Palbociclib, Fulvestrant)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Aug 12, 2022

Ewing Sarcoma, Ewing's Sarcoma Recurrent Trial in Boston (Palbociclib, Ganitumab)

Active, not recruiting
  • Ewing Sarcoma
  • Ewing's Sarcoma Recurrent
  • Boston, Massachusetts
  • +2 more
Mar 21, 2022

Cancer of the Colon, Colon Cancer, Colon Tumors Trial in Chapel Hill (Cetuximab, Palbociclib)

Recruiting
  • Cancer of the Colon
  • +4 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Jan 25, 2022

Colorectal Carcinoma, Lung Adenocarcinoma, Malignant Solid Tumor Trial in Buffalo (Binimetinib, Palbociclib, Therapeutic

Recruiting
  • Colorectal Carcinoma
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
May 11, 2022

Tumor, Solid, Pancreatic Cancer Trial in Chapel Hill (Ulixertinib, Palbociclib)

Active, not recruiting
  • Tumor, Solid
  • Pancreatic Cancer
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Jan 6, 2022

Breast Cancer, Breast Carcinoma, Cancer of Breast Trial in Saint Louis, Lincoln (Palbociclib, Letrozole, Fulvestrant)

Active, not recruiting
Has Results
  • Breast Cancer
  • +3 more
  • Palbociclib
  • +7 more
  • Saint Louis, Missouri
  • +1 more
Jul 20, 2022

Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Los Angeles (procedure, drug, other)

Terminated
  • Estrogen Receptor Positive
  • +16 more
  • Biopsy of Breast
  • +5 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Apr 4, 2022

Metastatic Malignant Tumor to Brain Trial in Boston (Palbociclib)

Recruiting
  • Metastatic Malignant Neoplasm to Brain
  • Palbociclib
  • Boston, Massachusetts
  • +1 more
Oct 25, 2021

Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer Trial in Shanghai (Palbociclib, trastuzumab, pyrotinib)

Recruiting
  • Estrogen Receptor-positive Breast Cancer
  • HER2-positive Breast Cancer
  • Palbociclib
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Hospital
Sep 29, 2021